BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Su G, Luan Z, Wu F, Wang X, Tang X, Wu N, Wang K. Long-term follow-up of autologous stem cell transplantation for severe paediatric systemic lupus erythematosus. Clin Rheumatol 2013;32:1727-34. [PMID: 23925552 DOI: 10.1007/s10067-013-2324-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Yang L, Ren G, Chen W, Zhao L, Guo J, Ge Y, Zeng C, Hu W, Huang X, Zhang H. Long-term follow-up of autologous peripheral blood hematopoietic stem cell transplantation for refractory lupus nephritis—a series study of 20 patients. Lupus. [DOI: 10.1177/09612033221126848] [Reference Citation Analysis]
2 Achini‐gutzwiller FR, Snowden JA, Corbacioglu S, Greco R, Greco R, Alexander T, Snowden J, Badoglio M, Labopin M, Abinun M, Apte S, Arnold R, Domenech A, Brierley C, Burman J, Castilla‐llorente C, Cooper N, Daghia G, Daikeler T, Papa N, Vries‐bouwstra J, Farge D, Finke J, Hagglund H, Hawkey C, Henes J, Hiepe F, Jessop H, Kiely D, Kazmi M, Kirgizov K, Kramer E, Mancardi G, Marjanovic Z, Martin R, Martin T, Ma D, Moore J, Miller P, Muraro P, Oliveira M, Polushin A, Onida F, Simoes B, Puyade M, Resnick I, Ricart E, Rovira M, Saccardi R, Saif M, Sakellari I, Sharrack B, Snarski E, Scherer HU, Sossa C, Withers B, Wulffraat N, Zaccara E, Amrolia P, Ansari M, Balduzzi A, Corbacioglu S, Dalassier A, Dalle J, Diaz CH, Feuchtinger T, Locatelli F, Lucchini G, Galimard J, Vincent MG, Handgretinger R, Kleinschmidt K, Lawitschka A, Martinez AP, Peters C, Rocha V, Ruggeri A, Sedlacek P, Svec P, Toporski J, Yesilipek A; The EBMT Autoimmune Diseases (ADWP) and Paediatric Diseases (PDWP) Working Parties. Haematopoietic stem cell transplantation for severe autoimmune diseases in children: A review of current literature, registry activity and future directions on behalf of the autoimmune diseases and paediatric diseases working parties of the European Society for Blood and Marrow Transplantation. Br J Haematol. [DOI: 10.1111/bjh.18176] [Reference Citation Analysis]
3 Scheffler Mendoza SC, Rivas-larrauri FE, Rodríguez-lozano AL. Updates on Childhood-Onset Systemic Lupus Erythematosus. Common Pediatric Diseases: an Updated Review 2022. [DOI: 10.2174/9789815039658122010014] [Reference Citation Analysis]
4 Hikmah Z, Endaryanto A, Ugrasena IDG, Rahaju AS, Arifin S. Nigella sativa L. as immunomodulator and preventive effect on renal tissue damage of lupus mice induced by pristane. Heliyon 2022;8:e09242. [DOI: 10.1016/j.heliyon.2022.e09242] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Abinun M, Slatter MA. Haematopoietic stem cell transplantation in paediatric rheumatic disease. Curr Opin Rheumatol 2021;33:387-97. [PMID: 34261117 DOI: 10.1097/BOR.0000000000000823] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
6 de Silva NL, Seneviratne SL. Haemopoietic stem cell transplantation in Systemic lupus erythematosus: a systematic review. Allergy Asthma Clin Immunol 2019;15:59. [PMID: 31548842 DOI: 10.1186/s13223-019-0373-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
7 Lehman TJ, Taber SF, Nuruzzaman F. Systemic Lupus Erythematosus in Childhood and Adolescence. Dubois' Lupus Erythematosus and Related Syndromes 2019. [DOI: 10.1016/b978-0-323-47927-1.00041-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
8 Zhu J, Su G, Lai J, Dong B, Kang M, Li S, Zhou Z, Wu F. Long-term follow-up of autologous hematopoietic stem cell transplantation for refractory juvenile dermatomyositis: a case-series study. Pediatr Rheumatol Online J 2018;16:72. [PMID: 30458860 DOI: 10.1186/s12969-018-0284-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
9 Noroozinia F, Mahmoudzadeh L, Gharalari FH, Makhdoomi K, Abbasi A. Relationship between interstitial CD34 positive cells and active phase of lupus nephritis. Eur J Rheumatol 2018;5:254-7. [PMID: 30308141 DOI: 10.5152/eurjrheum.2018.18067] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
10 Sattwika PD, Mustafa R, Paramaiswari A, Herningtyas EH. Stem cells for lupus nephritis: a concise review of current knowledge. Lupus 2018;27:1881-97. [PMID: 30099942 DOI: 10.1177/0961203318793206] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
11 Thakkar UG, Vanikar AV, Trivedi HL. Stem cell therapy: An emerging modality in glomerular diseases. Cytotherapy 2017;19:333-48. [PMID: 28089754 DOI: 10.1016/j.jcyt.2016.11.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
12 Leung PSC, Shuai Z, Liu B, Shu SA, Sun L. Stem Cell Therapy in the Treatment of Rheumatic Diseases and Application in the Treatment of Systemic Lupus Erythematosus. Next-Generation Therapies and Technologies for Immune-Mediated Inflammatory Diseases 2017. [DOI: 10.1007/978-3-319-42252-7_9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
13 Zhong J, Yang HC, Fogo AB. A perspective on chronic kidney disease progression. Am J Physiol Renal Physiol 2017;312:F375-84. [PMID: 27974318 DOI: 10.1152/ajprenal.00266.2016] [Cited by in Crossref: 66] [Cited by in F6Publishing: 71] [Article Influence: 11.0] [Reference Citation Analysis]
14 Wang D, Sun L. Stem cell therapies for systemic lupus erythematosus: current progress and established evidence. Expert Rev Clin Immunol 2015;11:763-9. [PMID: 25896297 DOI: 10.1586/1744666X.2015.1037741] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
15 Liu B, Shu S, Kenny TP, Chang C, Leung PSC. Stem Cell Therapy in Autoimmune Rheumatic Diseases: a Comprehensive Review. Clinic Rev Allerg Immunol 2014;47:244-57. [DOI: 10.1007/s12016-014-8445-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
16 Jin M, Xie Y, Li Q, Chen X. Stem cell-based cell therapy for glomerulonephritis. Biomed Res Int 2014;2014:124730. [PMID: 25003105 DOI: 10.1155/2014/124730] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]